Montelukast Sodium
Kastorion
5 mg
INDICATION: Prophylaxis and chronic treatment of asthma; prevention of day and nighttime symptoms and relief of symptoms of allergic rhinitis
GENERIC NAME: Montelukast (as Sodium)
DOSAGE STRENGTH/FORM: 5 mg Chewable Tablet
PRESENTATION: 25 tablets/blister pack x 5's
MANUFACTURER: Micro Labs. Ltd., India
FDA REG. NO. DR-XY35294
SHELF-LIFE: 36 months
Montelukast Sodium
Kastorion
10 mg
INDICATION: Prophylaxis and chronic treatment of asthma; prevention of day and nighttime symptoms and relief of symptoms of allergic rhinitis
GENERIC NAME: Montelukast (as Sodium)
DOSAGE STRENGTH/FORM: 10 mg Film-Coated Tablet
PRESENTATION: 25 tablets/blister pack x 5's
MANUFACTURER: Micro Labs. Ltd., India
FDA REG. NO. DR-XY35274
SHELF-LIFE: 36 months
Beclometasone Dipropionate + Formoterol Fumarate Dihydrate
Foster
100 mcg + 6 mcg
Contents:
A Fixed Dose Combination of Beclometasone dipropionate 100 mcg and formoterol fumarate dihydrate 6 mcg. Foster comes in Pressurized Inhalation Solution and Dry Powder Inhaler.
Indications and Usage:
For Asthma: Beclomethasone dipropionate/Formoterol fumarate dihydrate (Foster) is indicated in the regular treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate: patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled rapid-acting beta2-agonist or patients already adequately controlled on both inhaled corticosteroids and long-acting beta2-agonists.
For COPD: Symptomatic treatment of patients with severe COPD (FEV1 <50% predicted normal) and a history of repeated exacerbations, who have significant symptoms despite regular therapy with long-acting bronchodilators.
MANUFACTURER: Chiesi Farmaceutici, S.p.A., Italy
FDA REG. NO. DR-XY42146
SHELF-LIFE: 17 months
Our Products
